Predictive Role of Baseline Eosinophil Count in Metastatic Melanoma Treated with Nivolumab and Ipilimumab

EJC Skin Cancer · Published 2026-01-01 · DOI 10.1016/j.ejcskn.2026.100884

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.ejcskn.2026.100884

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Related articles